Contraceptives Market

Contraceptives Market (Product: Contraceptive Drugs and Contraceptive Devices; and Distribution Channel) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Contraceptives Market Outlook 2028

  • The global market was valued at US$ 893.9 Mn in 2020
  • It is estimated to expand at a CAGR of 15.5% from 2021 to 2028
  • The global contraceptives industry is expected to cross the value of US$ 2.7 Bn by the end of 2028

Analysts’ Viewpoint on Market Scenario

Birth spacing methods amid the ongoing COVID-19 pandemic include precise advice on lactation amenorrhoea method (LAM) to enhance its efficacy, barrier methods such as condoms, and plentiful supplies of oral progestin-only pill, among others. The global contraceptives market is highly fragmented, with the presence of a large number of international as well as regional players. Since there is a lack of awareness about the advantages of contraceptives in developing economies, market stakeholders should initiate collaborative agreements with governments to educate women as well as related individuals about different alternatives. Manufacturers should increase the production of affordable contraceptive options to boost their uptake in developing economies.

High Prevalence of Sexually Transmitted Infections Propels Demand for Contraceptives

A number of international and national organizations have initiated STI (sexually transmitted infections) awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.

The increase in the adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptive market. People across the world have become more aware of the need for family planning.

Request a sample to get extensive insights into the Contraceptives Market

Birth Spacing Helps Reduce Burden on Healthcare Systems amid COVID-19 Pandemic

The COVID-19 pandemic has heightened the importance of family planning since most people have been spending time indoors. Manufacturers in the global market for contraceptives are capitalizing on this opportunity to ensure an uninterrupted supply of oral contraceptives, contraceptive injectables, and contraceptive devices. Healthcare organizations are stressing on the advantages of birth spacing during the ongoing pandemic, since avoiding pregnancy during such uncertain times is wise for women not only on a personal level but also from a public health perspective in terms of not adding to overburdened healthcare systems. Manufacturers are increasing efforts to prevent stock-outs for implants, oral contraceptive pills, and copper intrauterine devices.

To understand how our report can bring a difference to your business strategy, Ask for a brochure

A comprehensive Product Portfolio Allows Stakeholders to Expand Income Sources

The contraceptives market is likely to provide new vendors with significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the market.

Oral (pill) contraceptives, topical contraceptives, and injectable contraceptives are various types of contraceptives. Contraceptive devices, on the other hand, include condoms, intrauterine devices (IUD), vaginal rings, implants, patches, diaphragms, sponges, etc. The barrier method, particularly condoms, is the most common form of artificial contraception.

The global contraceptive market is expected to be driven by an increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies.

Stuck in a neck-to-neck competition with other brands? Request a custom report on the Contraceptives Market

Lack of Knowledge about the Advantages of Contraceptives Hampers Market Growth

Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women in Asia use modern contraception at a lower rate than the global average. In Asia, the majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion.

Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in this market. Hence, participants in the market should collaborate with governments to increase awareness about the advantages of contraceptives, which holds the potential to boost product sales.

U.S. Sets Benchmark for Contraceptive Innovation and Collaborative Agreements

Key players in the global contraceptives industry are engaged in regulatory approvals, innovations in technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptive market. A few expansion strategies adopted by players operating in the global contraceptive market are announcing the generic versions of vaginal rings in the U.S. The launch of such vaginal rings can be expected to drive the market for contraceptives.

Healthcare organizations are launching global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market. At the same time, manufacturers are investing in R&D to increase the availability of FDA (Food and Drug Administration)-approved contraceptive options.

Contraceptives Industry: Overview

  • According to Transparency Market Research’s latest report on the global contraceptives market for the historical period 2017-2018 and forecast period 2019-2027, the decline in prices and an increase in access to contraceptives are projected to drive the global market during the forecast period

A rise in Prevalence of Sexually Transmitted Diseases Drives Demand for Contraceptive Tablets and Other Forms of Contraception

  • A number of international and national organizations have initiated STI awareness campaigns. Additionally, regulatory agencies in the U.K., such as the Medicines and Healthcare Regulatory Agency (MHRA), have approved injectable contraceptives. These approvals for women and men are expected to boost the growth of the global contraceptive market, particularly in developed countries.
  • The increase in the adoption of innovative contraceptive technologies in emerging countries is another factor propelling the global contraceptive market. People across the world have become more aware of the need for family planning.

Entry of New Vendors with Advanced Contraceptive Methods: Key Driver

  • The global contraceptives market is likely to provide new vendors with significant growth prospects, particularly in emerging countries. These companies can raise awareness and initiate activities about the usage of contraceptive devices. This is projected to increase contraceptive sales. Moreover, these new providers intend to expand their product offerings by introducing enhanced contraceptive devices. This is anticipated to boost the growth of the global contraceptive market.

Lack of Awareness about the Application of Contraceptive Devices in Emerging Countries

  • Women with unmet contraception needs rarely state that they are unaware of contraception, do not have access to a source of supply, or that it is too expensive. Women of Asia use modern contraception at a lower rate than the global average.
  • In Asia, the majority of unintended pregnancies are caused by the use of traditional contraception or the lack thereof, which results in induced unsafe abortion
  • Key barriers to modern contraceptive practice among women in Asia are cultural attitudes, lack of knowledge about methods and reproduction, socio-demographic factors, and healthcare barriers. Lack of knowledge and access could be the most straightforward issues to address in the global contraceptive market.

Contraceptives Market: Competition Landscape

  • This report profiles major players in the global contraceptives market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • The global market is highly fragmented, with the presence of a large number of international as well as regional players
  • Leading players operating in the global contraceptives business are
    • Merck & Co., Inc., Cipla, Inc.
    • Allergan plc
    • Bayer AG
    • HLL Lifecare Limited
    • Mankind Pharma
    • Pfizer, Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mithra Pharmaceuticals
    • Janssen Pharmaceutical Company
    • Reckitt Benckiser Group plc., etc.

Contraceptives Market: Key Developments

  • Key players in the global contraceptives market are engaged in regulatory approvals, technologically advanced products, the launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global contraceptive market. A few expansion strategies adopted by players operating in the global market are:
    • On January 14, 2021, Teva Pharmaceuticals announced the generic version of NuvaRing (etonogestrel and Ethinyl estradiol) vaginal ring in the U.S. The launch of such vaginal rings can be expected to drive the contraceptive market.
    • On November 17, 2020, the World Health Organization launched global strategies for accelerating the abolition of cervical cancer. This is expected to augment the global contraception devices market.
    • On May 22, 2020, Evofem Biosciences, Inc. announced that the U.S. Food and Drug Administration had approved Phexxi, a new contraceptive method
  • The report on the global contraceptive market discussed individual strategies, followed by company profiles of manufacturers of contraceptive devices. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global contraceptive market.

Contraceptives Market Snapshot

Attribute Detail
Market Size Value in 2020 US$ 893.9 Mn
Market Forecast Value in 2028 US$ 2,764.7 Mn
Growth Rate (CAGR) 15.5%
Forecast Period 2021-2028
Quantitative Units US$ Mn for Value
Market Analysis It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview.
Competition Landscape
  • Market share analysis by company (2020)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials
Format Electronic (PDF) + Excel
Market Segmentation
  • By Product
    • Contraceptive Drugs
      • Oral Contraceptives
        • Combined Contraceptives
        • Mini-pills
      • Contraceptive Injectable
      • Topical Contraceptive Patch
    • Contraceptive Devices
      • Male Contraceptive Devices
      • Female Contraceptive Devices
        • Female Condoms
        • Contraceptive Diaphragms
        • Contraceptive Sponges
        • Contraceptive Vaginal Rings
        • Intrauterine Devices
        • Sub-dermal Contraceptives Implants
        • Non-Surgical Permanent Contraception Devices
  • Contraceptives Market, by Distribution Channel
    • Hospitals Pharmacies
      • Public
      • Private
    • Independent Pharmacies
    • Online Pharmacies
    • Clinics
    • Others
Regions Covered
  • North America
  • Latin America
  • Europe
  • Latin America
  • Middle East & Africa
Countries Covered
  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
Companies Profiled
  • Merck & Co., Inc.
  • Cipla Inc.
  • Allergan plc
  • Bayer AG
  • HLL Lifecare Limited
  • Mankind Pharma
  • Pfizer, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Mithra Pharmaceuticals
  • Janssen Pharmaceutical Company
  • Reckitt Benckiser Group plc.
  • Other Prominent Players.
Customization Scope Available upon request
Pricing Available upon request

Contraceptives Market - Segmentation

Attribute Detail
Product
  • Contraceptive Drugs
    • Oral Contraceptives
      • Combined Contraceptives
      • Mini-pills
    • Contraceptive Injectable
    • Topical Contraceptive Patch
  • Contraceptive Devices
    • Male Contraceptive Devices
    • Female Contraceptive Devices
  • Tissue Engineering
Distribution Channel
  • Hospitals Pharmacy
    • Public
    • Private
  • Independent Pharmacy
  • Online Platform
  • Clinics
  • Others
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Frequently Asked Questions

What is the total market worth of contraceptives market?

The global Contraceptives industry is expected to cross the value of US$ 2.7 Bn by the end of 2028

What is the anticipated CAGR of the market for contraceptives in the forecast period?

The global market is estimated to expand at a CAGR of 15.5% from 2021 to 2028

What are the key driving factors for the growth of the contraceptives business?

The global market for contraceptives is driven by an increase in efforts by governments to raise awareness about the negative effects of population growth and unwanted pregnancies

Which region is expected to project the highest market share in the global contraceptive market?

North America dominated the global market and the region is expected to account for a major share of the global contraceptives market during the forecast period

Who are the key players in the global contraceptives industry?

Key players in the global market include Smith & Nephew plc, Anika Therapeutics, Inc., DePuy Synthes, Inc., Baxter International, Inc., Stryker Corporation, Medtronic, Inc., Arthrex, Inc.

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Contraceptives Market

    4. Market Overview

        4.1. Introduction

        4.2. Overview

        4.3. Key Market Indicators

        4.4. Market Dynamics

            4.4.1. Drivers

            4.4.2. Restraints

            4.4.3. Opportunity

        4.5. Global Contraceptives Market Analysis and Forecast, 2017-2028

            4.5.1. Market Revenue Projections (US$ Mn)

        4.6. Global Contraceptives Market - Global Supply Demand Scenario

        4.7. Porter’s Five Force Analysis

        4.8. Value Chain Analysis

        4.9. Market Outlook

    5. Global Contraceptives Market Analysis and Forecast, By Product

        5.1. Introduction & Definition

        5.2. Key Findings / Developments

        5.3. Key Trends

        5.4. Market Value Forecast, by Product, 2017-2028

            5.4.1. Contraceptives Drugs

                5.4.1.1. Oral Contraceptives

                    5.4.1.1.1. Combined Contraceptives

                    5.4.1.1.2. Mini-pills

                5.4.1.2. Contraceptive Injectable

                5.4.1.3. Topical Contraceptive Patch

            5.4.2. Contraceptive Devices

                5.4.2.1. Male Contraceptive Devices

                5.4.2.2. Female Contraceptive Devices

                    5.4.2.2.1. Female Condoms

                    5.4.2.2.2. Contraceptive Diaphragms

                    5.4.2.2.3. Contraceptive Sponges

                    5.4.2.2.4. Contraceptive Vaginal Rings

                    5.4.2.2.5. Intrauterine Devices

                    5.4.2.2.6. Sub-dermal Contraceptives Implants

                    5.4.2.2.7. Non-Surgical Permanent Contraception Devices

        5.5. Market Attractiveness Analysis, By Product

    6. Global Contraceptives Market Analysis and Forecast, By Distribution Channel

        6.1. Introduction & Definition

        6.2. Key Findings / Developments

        6.3. Key Trends

        6.4. Market Value Forecast, by Distribution Channel, 2017-2028

            6.4.1. Hospital Pharmacy

                6.4.1.1. Public

                6.4.1.2. Private

            6.4.2. Independent Pharmacy

            6.4.3. Online Platform

            6.4.4. Clinics

            6.4.5. Others

        6.5. Market Attractiveness Analysis, By Distribution Channel

    7. Global Contraceptives Market Analysis and Forecast, By Region

        7.1. Key Findings

        7.2. Policies and Regulations

        7.3. Market Value Forecast, by Region

            7.3.1. North America

            7.3.2. Europe

            7.3.3. Asia Pacific

            7.3.4. Latin America

            7.3.5. Middle East and Africa

        7.4. Market Attractiveness Analysis, By Country/Region

    8. North America Contraceptives Market Analysis and Forecast

        8.1. Introduction

            8.1.1. Key Findings

            8.1.2. Policies and Regulations

            8.1.3. Key Trends

        8.2. Market Value Forecast, by Product, 2017-2028

            8.2.1. Contraceptive Drugs

                8.2.1.1. Oral Contraceptives

                    8.2.1.1.1. Combined Contraceptives

                    8.2.1.1.2. Mini-pills

                8.2.1.2. Contraceptive Injectable

                8.2.1.3. Topical Contraceptive Patch

            8.2.2. Contraceptive Devices

                8.2.2.1. Male Contraceptive Devices

                8.2.2.2. Female Contraceptive Devices

                    8.2.2.2.1. Female Condoms

                    8.2.2.2.2. Contraceptive Diaphragms

                    8.2.2.2.3. Contraceptive Sponges

                    8.2.2.2.4. Contraceptive Vaginal Rings

                    8.2.2.2.5. Intrauterine Devices

                    8.2.2.2.6. Sub-dermal Contraceptives Implants

                    8.2.2.2.7. Non-Surgical Permanent Contraception Devices

        8.3. Market Value Forecast, by Distribution Channel, 2017-2028

            8.3.1. Hospital Pharmacy

                8.3.1.1. Public

                8.3.1.2. Private

            8.3.2. Independent Pharmacy

            8.3.3. Online Platform

            8.3.4. Clinics

            8.3.5. Others

        8.4. Market Value Forecast, by Country, 2017-2028

            8.4.1. U.S.

            8.4.2. Canada

        8.5. Market Attractiveness Analysis

            8.5.1. By Product

            8.5.2. By Distribution Channel

            8.5.3. By Country

    9. Europe Contraceptives Market Analysis and Forecast

        9.1. Introduction

            9.1.1. Key Findings

            9.1.2. Policies and Regulations

            9.1.3. Key Trends

        9.2. Market Value Forecast, by Product, 2017-2028

            9.2.1. Contraceptive Drugs

                9.2.1.1. Oral Contraceptives

                    9.2.1.1.1. Combined Contraceptives

                    9.2.1.1.2. Mini-pills

                9.2.1.2. Contraceptive Injectable

                9.2.1.3. Topical Contraceptive Patch

            9.2.2. Contraceptive Devices

                9.2.2.1. Male Contraceptive Devices

                9.2.2.2. Female Contraceptive Devices

                    9.2.2.2.1. Female Condoms

                    9.2.2.2.2. Contraceptive Diaphragms

                    9.2.2.2.3. Contraceptive Sponges

                    9.2.2.2.4. Contraceptive Vaginal Rings

                    9.2.2.2.5. Intrauterine Devices

                    9.2.2.2.6. Sub-dermal Contraceptives Implants

                    9.2.2.2.7. Non-Surgical Permanent Contraception Devices

        9.3. Market Value Forecast, by Distribution Channel, 2017-2028

            9.3.1. Hospital Pharmacy

                9.3.1.1. Public

                9.3.1.2. Private

            9.3.2. Independent Pharmacy

            9.3.3. Online Platform

            9.3.4. Clinics

            9.3.5. Others

        9.4. Market Value Forecast, by Country/Sub-region, 2017-2028

            9.4.1. Germany

            9.4.2. France

            9.4.3. U.K.

            9.4.4. Spain

            9.4.5. Italy

            9.4.6. Russia

            9.4.7. Rest of Europe

        9.5. Market Attractiveness Analysis

            9.5.1. By Product

            9.5.2. By Distribution Channel

            9.5.3. By Country/Sub-region

    10. Asia Pacific Contraceptives Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

            10.1.2. Policies and Regulations

            10.1.3. Key Trends

        10.2. Market Value Forecast, by Product, 2017-2028

            10.2.1. Contraceptive Drugs

                10.2.1.1. Oral Contraceptives

                    10.2.1.1.1. Combined Contraceptives

                    10.2.1.1.2. Mini-pills

                10.2.1.2. Contraceptive Injectable

                10.2.1.3. Topical Contraceptive Patch

            10.2.2. Contraceptive Devices

                10.2.2.1. Male Contraceptive Devices

                10.2.2.2. Female Contraceptive Devices

                    10.2.2.2.1. Female Condoms

                    10.2.2.2.2. Contraceptive Diaphragms

                    10.2.2.2.3. Contraceptive Sponges

                    10.2.2.2.4. Contraceptive Vaginal Rings

                    10.2.2.2.5. Intrauterine Devices

                    10.2.2.2.6. Sub-dermal Contraceptives Implants

                    10.2.2.2.7. Non-Surgical Permanent Contraception Devices

        10.3. Market Value Forecast, by Distribution Channel, 2017-2028

            10.3.1. Hospital Pharmacy

                10.3.1.1. Public

                10.3.1.2. Private

            10.3.2. Independent Pharmacy

            10.3.3. Online Platforms

            10.3.4. Clinics

            10.3.5. Others

        10.4. Market Value Forecast, by Country/Sub-region, 2017-2028

            10.4.1. China

            10.4.2. Japan

            10.4.3. India

            10.4.4. Australia & New Zealand

            10.4.5. Rest of Asia Pacific

        10.5. Market Attractiveness Analysis

            10.5.1. By Product

            10.5.2. By Distribution Channel

            10.5.3. By Country/Sub-region

    11. Latin America Contraceptives Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

            11.1.2. Policies and Regulations

            11.1.3. Key Trends

        11.2. Market Value Forecast, by Product, 2017-2028

            11.2.1. Contraceptive Drugs

                11.2.1.1. Oral Contraceptives

                    11.2.1.1.1. Combined Contraceptives

                    11.2.1.1.2. Mini-pills

                11.2.1.2. Contraceptive Injectable

                11.2.1.3. Topical Contraceptive Patch

            11.2.2. Contraceptive Devices

                11.2.2.1. Male Contraceptive Devices

                11.2.2.2. Female Contraceptive Devices

                    11.2.2.2.1. Female Condoms

                    11.2.2.2.2. Contraceptive Diaphragms

                    11.2.2.2.3. Contraceptive Sponges

                    11.2.2.2.4. Contraceptive Vaginal Rings

                    11.2.2.2.5. Intrauterine Devices

                    11.2.2.2.6. Sub-dermal Contraceptives Implants

                    11.2.2.2.7. Non-Surgical Permanent Contraception Devices

        11.3. Market Value Forecast, by Distribution Channel, 2017-2028

            11.3.1. Hospital Pharmacy

                11.3.1.1. Public

                11.3.1.2. Private

            11.3.2. Independent Pharmacy

            11.3.3. Online Platforms

            11.3.4. Clinics

            11.3.5. Others

        11.4. Market Value Forecast, by Country/Sub-region, 2017-2028

            11.4.1. Brazil

            11.4.2. Mexico

            11.4.3. Rest of Latin America

        11.5. Market Attractiveness Analysis

            11.5.1. By Product

            11.5.2. By Distribution Channel

            11.5.3. By Country/Sub-region

    12. Middle East and Africa Contraceptives Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

            12.1.2. Policies and Regulations

            12.1.3. Key Trends

        12.2. Market Value Forecast, by Product, 2017-2028

            12.2.1. Contraceptive Drugs

                12.2.1.1. Oral Contraceptives

                    12.2.1.1.1. Combined Contraceptives

                    12.2.1.1.2. Mini-pills

                12.2.1.2. Contraceptive Injectable

                12.2.1.3. Topical Contraceptive Patch

            12.2.2. Contraceptive Devices

                12.2.2.1. Male Contraceptive Devices

                12.2.2.2. Female Contraceptive Devices

                    12.2.2.2.1. Female Condoms

                    12.2.2.2.2. Contraceptive Diaphragms

                    12.2.2.2.3. Contraceptive Sponges

                    12.2.2.2.4. Contraceptive Vaginal Rings

                    12.2.2.2.5. Intrauterine Devices

                    12.2.2.2.6. Sub-dermal Contraceptives Implants

                    12.2.2.2.7. Non-Surgical Permanent Contraception Devices

        12.3. Market Value Forecast, by End User, 2017-2028

            12.3.1. Hospital Pharmacy

                12.3.1.1. Public

                12.3.1.2. Private

            12.3.2. Independent Pharmacy

            12.3.3. Online Platform

            12.3.4. Clinics

            12.3.5. Others

        12.4. Market Value Forecast, by Country /Sub-region, 2017-2028

            12.4.1. GCC Countries

            12.4.2. South Africa

            12.4.3. Rest of Middle East and Africa

        12.5. Market Attractiveness Analysis

            12.5.1. By Product

            12.5.2. By Distribution Channel

            12.5.3. By Country/Sub-region

    13. Competition Landscape

        13.1. Market Player - Competition Matrix (by tier and size of companies)

        13.2. Market Share Analysis, by Company, 2020

        13.3. Company Profiles

            13.3.1. Merck & Co., Inc.

                13.3.1.1. Overview

                13.3.1.2. Financials

                13.3.1.3. Recent Developments

                13.3.1.4. Strategy

            13.3.2. Cipla, Inc.

                13.3.2.1. Overview

                13.3.2.2. Financials

                13.3.2.3. Recent Developments

                13.3.2.4. Strategy

            13.3.3. Allergan plc

                13.3.3.1. Overview

                13.3.3.2. Financials

                13.3.3.3. Recent Developments

                13.3.3.4. Strategy

            13.3.4. Bayer AG

                13.3.4.1. Overview

                13.3.4.2. Financials

                13.3.4.3. Recent Developments

                13.3.4.4. Strategy

            13.3.5. HLL Lifecare Limited

                13.3.5.1. Overview

                13.3.5.2. Financials

                13.3.5.3. Recent Developments

                13.3.5.4. Strategy

            13.3.6. Mankind Pharma

                13.3.6.1. Overview

                13.3.6.2. Financials

                13.3.6.3. Recent Developments

                13.3.6.4. Strategy

            13.3.7. Pfizer, Inc.

                13.3.7.1. Overview

                13.3.7.2. Financials

                13.3.7.3. Recent Developments

                13.3.7.4. Strategy

            13.3.8. Teva Pharmaceutical Industries Ltd.

                13.3.8.1. Overview

                13.3.8.2. Financials

                13.3.8.3. Recent Developments

                13.3.8.4. Strategy

            13.3.9. Mithra Pharmaceuticals

                13.3.9.1. Overview

                13.3.9.2. Financials

                13.3.9.3. Recent Developments

                13.3.9.4. Strategy

            13.3.10. Janssen Pharmaceutical Company

                13.3.10.1. Overview

                13.3.10.2. Financials

                13.3.10.3. Recent Developments

                13.3.10.4. Strategy

            13.3.11. Reckitt Benckiser Group plc

                13.3.11.1. Overview

                13.3.11.2. Financials

                13.3.11.3. Recent Developments

                13.3.11.4. Strategy

    List of Tables

    Table 01: Global Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 02: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 03: Global Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 04: Global Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 05: Global Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 06: Global Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 07: Global Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    Table 08: Global Contraceptives Market Size (US$ Mn) Forecast, by Region, 2017-2028

    Table 09: North America Contraceptives Market Size (US$ Mn) Forecast, by Country, 2017-2028

    Table 10: North America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 11: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 12: North America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 13: North America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 14: North America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 15: North America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 16: North America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    Table 17: Europe Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 18: Europe Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 19: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 20: Europe Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 21: Europe Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 22: Europe Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 23: Europe Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 24: Europe Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    Table 25: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 26: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 27: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 28: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 29: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 30: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 31: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 32: Asia Pacific Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    Table 33: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 34: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 35: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 36: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 37: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 38: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 39: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 40: Latin America Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    Table 41: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2028

    Table 42: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Product Type, 2017-2028

    Table 43: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2017-2028

    Table 44: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2017-2028

    Table 45: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2017-2028

    Table 46: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2017-2028

    Table 47: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Distribution Channel, 2017-2028

    Table 48: Middle East & Africa Contraceptives Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2017-2028

    List of Figures

    Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2017-2028

    Figure 02: Global Contraceptives Market Value Share, by Product (2020)

    Figure 03: Global Contraceptives Market Value Share, by Distribution Channel, 2020

    Figure 04: Global Contraceptives Market Value Share, by Region, 2020

    Figure 05: Global Contraceptives Market Value Share, by Product Type, 2017 and 2028

    Figure 06: Global Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028

    Figure 07: Global Contraceptives Market Value Share, by Contraceptive Drugs, 2017 and 2028

    Figure 08: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Drugs, 2017-2028

    Figure 09: Global Contraceptives Market Value Share, by Oral Contraceptives, 2017 and 2028

    Figure 10: Global Contraceptives Market Attractiveness Analysis, by Oral Contraceptives, 2017-2028

    Figure 11: Global Contraceptives Market Value Share, by Contraceptive Devices, 2017 and 2028

    Figure 12: Global Contraceptives Market Attractiveness Analysis, by Contraceptive Devices, 2017-2028

    Figure 13: Global Contraceptives Market Value Share, by Female Contraceptive Devices, 2017 and 2028

    Figure 14: Global Contraceptives Market Attractiveness Analysis, by Female Contraceptive Devices, 2017-2028

    Figure 15: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2017-2028

    Figure 16: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2017-2028

    Figure 17: Global Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 18: Global Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 19: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2017-2028

    Figure 20: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2017-2028

    Figure 21: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2017-2028

    Figure 22: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2017-2028

    Figure 23: Global Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2028

    Figure 24: Global Contraceptives Market Value Share, by Region, 2017 and 2028

    Figure 25: Global Contraceptives Market Attractiveness Analysis, by Region, 2017-2028

    Figure 26: North America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028

    Figure 27: North America Contraceptives Market Attractiveness Analysis, by Country 2017-2028

    Figure 28: North America Contraceptives Market Value Share, by Country, 2017 and 2028

    Figure 29: North America Contraceptives Market Value Share, by Product Type, 2017 and 2028

    Figure 30: North America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028

    Figure 31: North America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 32: North America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 33: Europe Contraceptives Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2028

    Figure 34: Europe Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 35: Europe Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

    Figure 36: Europe Contraceptives Market Value Share, by Product, 2017 and 2028

    Figure 37: Europe Contraceptives Market Attractiveness Analysis, by Product, 2017-2028

    Figure 38: Europe Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 39: Europe Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 40: Asia Pacific Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028

    Figure 41: Asia Pacific Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 42: Asia Pacific Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

    Figure 43: Asia Pacific Contraceptives Market Value Share, by Product Type, 2017 and 2028

    Figure 44: Asia Pacific Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028

    Figure 45: Asia Pacific Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 46: Asia Pacific Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 47: Latin America Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028

    Figure 48: Latin America Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 49: Latin America Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

    Figure 50: Latin America Contraceptives Market Value Share, by Product Type, 2017 and 2028

    Figure 51: Latin America Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028

    Figure 52: Latin America Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 53: Latin America Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 54: Middle East & Africa Contraceptives Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017-2028

    Figure 55: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Country/Sub-region, 2017-2028

    Figure 56: Middle East & Africa Contraceptives Market Value Share, by Country/Sub-region, 2017 and 2028

    Figure 57: Middle East & Africa Contraceptives Market Value Share, by Product Type, 2017 and 2028

    Figure 58: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Product Type, 2017-2028

    Figure 59: Middle East & Africa Contraceptives Market Value Share, by Distribution Channel, 2017 and 2028

    Figure 60: Middle East & Africa Contraceptives Market Attractiveness Analysis, by Distribution Channel, 2017-2028

    Figure 61: Global Contraceptives Drugs Market Share, by Company, 2020

    Figure 62: Global Contraceptives Devices Market Share, by Company, 2020

Copyright © Transparency Market Research, Inc. All Rights reserved